Form 4: AdaptHealth COO Receives Equity Grant
Statement of Changes in Beneficial Ownership
AdaptHealth Corp. Chief Operating Officer Daniel Edward McFadden acquired 20,134 restricted stock units.
Summary
- Daniel Edward McFadden, Chief Operating Officer of AdaptHealth Corp., was granted 20,134 restricted stock units (RSUs) on May 27, 2026.
- The transaction was executed at a price of $0 per share, representing an equity incentive grant.
- Following this transaction, the reporting person's total beneficial ownership of common stock increased to 103,376 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant market-moving sentiment.
Positives
- The equity grant aligns the interests of the Chief Operating Officer with those of shareholders through long-term incentive compensation.
Negatives
- The issuance of additional restricted stock units results in potential future dilution for existing shareholders upon vesting.
Risks
- The value of the granted equity is subject to market volatility and the future performance of AdaptHealth Corp. common stock.
Future Outlook
The restricted stock units will be settled in common stock upon vesting, subject to the company's standard equity incentive plan terms.
Industry Context
StockSavvy.ai notes that equity grants to C-suite executives are standard corporate governance practices intended to retain leadership and incentivize long-term operational performance within the healthcare services sector.
Comparison to Industry Standards
- The grant of restricted stock units is consistent with standard executive compensation packages for publicly traded healthcare companies.
- The reporting of this transaction via Form 4 complies with SEC Section 16(a) disclosure requirements.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual vesting and settlement of these units.
Next Steps
- Vesting of the restricted stock units according to the company's internal equity plan schedule.
Key Dates
| Date | Description |
|---|---|
| 05/27/2026 | Date of the earliest transaction involving the acquisition of restricted stock units. |
| 05/29/2026 | Date of filing the Form 4 with the SEC. |
Keywords
AdaptHealth, AHCO, Form 4, Insider Transaction, Equity Compensation, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.